CordenPharma to Acquire Peptisyntha SA from Solvay - - BioPharm International

ADVERTISEMENT

CordenPharma to Acquire Peptisyntha SA from Solvay



International Chemical Investors Group (ICIG) and the Solvay Group have formed an agreement under which ICIG will acquire Peptisyntha SA, the Brussels-based custom manufacturer of peptides. Upon closing of the deal, expected later this fall, Peptisyntha will become a member of ICIG’s CordenPharma platform as its third site offering peptide manufacturing.

Although the US sister company Peptisyntha Inc., located in Torrance, California, is not part of the transaction, certain customer relationships will be assumed by Peptisyntha in Brussels.

Source: CordenPharma

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
Author Guidelines

Click here